These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9533004)

  • 1. Recombinant interferon-alpha therapy and meno-metrorrhagia.
    Uberti-Foppa C; Finazzi R; De Bona A
    Br J Obstet Gynaecol; 1998 Mar; 105(3):367-8. PubMed ID: 9533004
    [No Abstract]   [Full Text] [Related]  

  • 2. Primary biliary cirrhosis induced by interferon-alpha therapy for hepatitis C virus infection.
    D'Amico E; Paroli M; Fratelli V; Palazzi C; Barnaba V; Callea F; Consoli G
    Dig Dis Sci; 1995 Oct; 40(10):2113-6. PubMed ID: 7587775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of autoimmune polyglandular syndrome developed after interferon-alpha therapy.
    Sasso FC; Carbonara O; Di Micco P; Coppola L; Torella R; Niglio A
    Br J Clin Pharmacol; 2003 Aug; 56(2):238-9. PubMed ID: 12895200
    [No Abstract]   [Full Text] [Related]  

  • 4. Exacerbation of Graves ophthalmopathy with interferon-alpha therapy.
    DeMartelaere SL; Green MK; Shore JW
    Ophthalmic Plast Reconstr Surg; 2007; 23(4):319-21. PubMed ID: 17667110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy of hepatitis C: consensus interferon trials. Consensus Interferon Study Group.
    Keeffe EB; Hollinger FB
    Hepatology; 1997 Sep; 26(3 Suppl 1):101S-107S. PubMed ID: 9305673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anosmia induced with alpha interferon in a patient with chronic hepatitis C.
    Kraus I; Vitezic D
    Int J Clin Pharmacol Ther; 2000 Jul; 38(7):360-1. PubMed ID: 10919345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Consensus and peg-interferon in chronic hepatitis C. Therapy for refractory cases?].
    Kaiser S
    MMW Fortschr Med; 2001 Apr; 143(16):36-7. PubMed ID: 11367991
    [No Abstract]   [Full Text] [Related]  

  • 8. Lichen planus and interferon therapy for hepatitis C.
    Boccia S; Gamberini S; Dalla Libera M; Strumia R; Venturini D
    Gastroenterology; 1993 Dec; 105(6):1921-2. PubMed ID: 8253371
    [No Abstract]   [Full Text] [Related]  

  • 9. Interferon alpha-induced lupus: proof of principle.
    Niewold TB
    J Clin Rheumatol; 2008 Jun; 14(3):131-2. PubMed ID: 18525429
    [No Abstract]   [Full Text] [Related]  

  • 10. Hazards of interferon therapy for HBV-seronegative chronic hepatitis.
    Vento S; Di Perri G; Garofano T; Cosco L; Concia E; Ferraro T; Bassetti D
    Lancet; 1989 Oct; 2(8668):926. PubMed ID: 2571851
    [No Abstract]   [Full Text] [Related]  

  • 11. [Natural history of dysthyroidism during interferon treatment of chronic hepatitis C].
    Mekkakia-Benhabib C; Marcellin P; Colas-Linhart N; Castel-Nau C; Buyck D; Erlinger S; Bok B
    Ann Endocrinol (Paris); 1996; 57(5):419-27. PubMed ID: 8991106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Observation on the efficacy and safety of Infergen combined with capsule ribavirin in treatment of hepatitis C patients].
    Luo GH; Liao BM; Huang SB
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jun; 12(6):363. PubMed ID: 15225435
    [No Abstract]   [Full Text] [Related]  

  • 13. Exacerbation of multiple sclerosis after the administration of recombinant human interferon alfa.
    Larrey D; Marcellin P; Fréneaux E; Pessayre D; Benhamou JP
    JAMA; 1989 Apr; 261(14):2065. PubMed ID: 2494361
    [No Abstract]   [Full Text] [Related]  

  • 14. Immune thrombocytopenic purpura in a patient treated with interferon alfacon-1.
    Dimitroulopoulos D; Dourakis SP; Xinopoulos D; Tsamakidis K; Paraskevas E
    J Viral Hepat; 2004 Sep; 11(5):477-8. PubMed ID: 15357656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overwhelming diffuse psoriasis during chronic HCV infection, after peginterferon-ribavirin treatment, supported by frequent resort to filgrastim rescue.
    Sabbatani S; Manfredi R
    Braz J Infect Dis; 2010; 14(4):327. PubMed ID: 20963313
    [No Abstract]   [Full Text] [Related]  

  • 16. [Late fever under recombinant alfa interferon].
    Gaudin JL; Dumortier J; Souquet JC; Bel A
    Presse Med; 1994 Jun; 23(22):1041. PubMed ID: 7971811
    [No Abstract]   [Full Text] [Related]  

  • 17. Re: life-threatening severe immune thrombocytopenia after alpha-interferon therapy for chronic hepatitis C infection.
    Khan HA; Khawaja FI; Mahrous AR
    Am J Gastroenterol; 1996 Apr; 91(4):821-2. PubMed ID: 8677971
    [No Abstract]   [Full Text] [Related]  

  • 18. Elevated hepatic transaminases associated with the use of interferon alfacon-1 and ribavirin.
    Kleppinger EL; Ragan AP
    Am J Health Syst Pharm; 2009 Mar; 66(5):465-8. PubMed ID: 19233994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of chronic hepatitis C accompanied by polyarthritis during interferon treatment].
    Funaoka M; Komatsu M; Ono T; Nakajima K; Kato J; Kuramitsu T; Masamune O
    Nihon Shokakibyo Gakkai Zasshi; 1994 Feb; 91(2):212-6. PubMed ID: 8114330
    [No Abstract]   [Full Text] [Related]  

  • 20. [Peritonsillar and neck abscess with septicemia during interferon therapy in a patient with chronic hepatitis C].
    Shirahama M; Dohmen K; Miyamoto Y; Ohta Y; Irie K; Ishibashi H
    Nihon Shokakibyo Gakkai Zasshi; 1997 Apr; 94(4):295-9. PubMed ID: 9136588
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.